Medi-Physics to distribute Adenoscan
Radiopharmacy firm Medi-Physics has signed a deal with Fujisawato distribute its Adenoscan pharmacological stress agent, whichreceived Food and Drug Administration approval in May. Fujisawalicenses the agent from Medco Research. Medi-Physics, a
Radiopharmacy firm Medi-Physics has signed a deal with Fujisawato distribute its Adenoscan pharmacological stress agent, whichreceived Food and Drug Administration approval in May. Fujisawalicenses the agent from Medco Research.
Medi-Physics, a subsidiary of Amersham International, willdistribute Adenoscan through its network of 115 radiopharmacies.Medi-Physics, of Arlington Heights, IL, hopes to achieve synergiesbetween Adenoscan and its Myoview technetium-based cardiac imagingagent, which received an approvable letter from the Food and DrugAdministration last month (SCAN 8/2/95).
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
